相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:20COPD: Pathogenesis and Clinical Features
358
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
358
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Annals of palliative medicine·2021
Same author
Comparison of two mathematical prediction models in assessing the toxicity of heavy metal mixtures to the feeding of the nematode Caenorhabditis elegans.
Ecotoxicology and environmental safety·2013
目前关于COPD生物治疗的前景.
Ambedkar Kumar Yadav1, Wenhua Gu1, Tongyangzi Zhang1
1Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
COPD
|July 3, 2023
概括
新的抗炎生物制剂可以改善慢性阻塞性肺病 (COPD) 的管理. 了解COPD 的理解
科学领域:
- 肺病学和免疫学研究.
- 专注于呼吸道疾病和炎症.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂,异质的呼吸道疾病,对健康和经济产生重大影响.
- 目前的COPD治疗方法,主要是支气管扩展剂和皮质类固醇,提供有限的抗炎作用和疾病进展控制.
- 慢性肺炎的异质性需要新的治疗策略,超出目前的护理标准.
结论:
- 新型抗炎生物药物正在成为COPD的有希望的治疗途径.
- 更深入地了解COPD的炎症途径对于开发有效的治疗方法至关重要.
- 针对特定炎症机制的生物疗法可以改善COPD管理和患者的治疗结果.
